<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> (CA) was used in the treatment of 2 patients with acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Upon reaching hematological remission these children had recurrence consequent to dose lowering or discontinuation of CA </plain></SENT>
<SENT sid="2" pm="."><plain>The remission occurred again when full-dose CA treatment was resumed </plain></SENT>
<SENT sid="3" pm="."><plain>Slow 2-year decrease in CA dose led to uneventful end of CA treatment without deterioration of blood picture </plain></SENT>
</text></document>